| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 512 |
| 1 | ALEMTUZUMAB | 185 |
| 2 | NIVOLUMAB | 179 |
| 3 | ACETAMINOPHEN | 151 |
| 4 | METHOTREXATE SODIUM | 149 |
| 5 | ADALIMUMAB | 140 |
| 6 | INTERFERON BETA-1A | 136 |
| 7 | METHOTREXATE | 132 |
| 8 | LEVOTHYROXINE SODIUM ANHYDROUS | 125 |
| 9 | IPILIMUMAB | 111 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 364 |
| 1 | Corticosteroid [EPC] | 312 |
| 2 | Benzodiazepine [EPC] | 222 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 185 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 179 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 142 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 140 |
| 7 | Interferon beta [EPC] | 136 |
| 8 | Proton Pump Inhibitor [EPC] | 128 |
| 9 | Vitamin C [EPC] | 128 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 185 | 0.0096 |
| 1 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 2 | Ergot Derivative [EPC] | 13 | 0.0026 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 111 | 0.0023 |
| 4 | Human Immunoglobulin G [EPC] | 45 | 0.0021 |
| 5 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 8 | 0.0021 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 10 | 0.0020 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 179 | 0.0018 |
| 8 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |